A REVIEW OF LINK ALTERNATIF MBL77

Not all clients with CLL need therapy. In spite of all latest improvements, the iwCLL continue to recommends watchful observation for sufferers with asymptomatic condition.86 This suggestion is based on a minimum of two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103